Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS

NCT00559962 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: AEGR-733
DRUG: placebo
DRUG: AEGR-733
DRUG: AEGR-733
DRUG: AEGR-733
DRUG: AEGR-733 and atorvastatin
DRUG: AEGR-733 and fenofibrate
DRUG: AEGR-733 and ezetimibe

Sponsor

Aegerion Pharmaceuticals, Inc.